![](/img/cover-not-exists.png)
For ischemic brain damage, is preclinical evidence of neuroprotection by presynaptic blockade of glutamate release enough?
A.A. Nava-Ocampo, H. Reyes-Pérez, A.M. Bello-ramı&, #x0301, rez, A. Mansilla-Olivares, H. Ponce-MonterVolume:
54
Year:
2000
Language:
english
DOI:
10.1054/mehy.1998.0831
File:
PDF, 137 KB
english, 2000